China's Shenyang expands nucleic acid testing to stem new COVID-19 cases
SHENYANG -- Shenyang, capital of northeast China's Liaoning province, has expanded the scope of nucleic acid testing following new cases of COVID-19, said local health authorities.
On Tuesday afternoon, Shenyang launched nucleic acid testing for residents of more areas in the four districts where a total of four locally transmitted COVID-19 cases had been reported so far.
The testing is expected to be completed on Thursday, according to the authorities.
The province was hit by a new round of coronavirus infections on Friday, following which nucleic acid testing was immediately launched in key areas of Shenyang and the city of Yingkou.
On Monday, Liaoning reported four new confirmed locally transmitted COVID-19 cases -- two each in Shenyang and Yingkou.
- China Medical Expert Team arrives in DR Congo to aid battle against Ebola, leveraging expertise and China's experience in epidemic control: team members
- China to send medical expert team to DR Congo for Ebola control
- Senior WHO official highlights China's role in tackling global health challenges
- Focus on the World Health Assembly | Healthy China, not just China
- China builds robust nursing workforce amid healthcare push
- NHC minister meets with president of Merieux Foundation


